Albert David Limited
ALBERTDA.BO- 1D
- -0.5%
Albert David Limited in brief
Albert David Limited is a listed company in the Pharmaceutical industry, based in India. Its market value was $46 M on 19 November 2026, which makes it the 21,534th largest listed company in the world and the 1,913th largest in India on this site. Its shares trade under the symbol ALBERTDA.BO (BSE).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Albert David Limited timeline
- 2016
- 📈Listed on National Stock Exchange of India as ALBERTDAVDFirst day of listing in the exchange's official list.
Events of Albert David Limited from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Albert David Limited share price · NSE (ALBERTDAVD.NS)
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Nov 19, 2026 | 755.10 | 767.35 | 754.10 | 755.35 | -0.6% | 818 |
| Nov 18, 2026 | 761.40 | 774.95 | 751.00 | 759.90 | -1.1% | 1,563 |
| Nov 17, 2026 | 789.25 | 790.00 | 768.10 | 768.70 | -1.3% | 2,371 |
| Nov 16, 2026 | 787.00 | 797.80 | 774.90 | 778.90 | -0.8% | 654 |
| Nov 13, 2026 | 785.00 | 795.00 | 765.70 | 785.00 | -0.5% | 2,693 |
| Nov 12, 2026 | 805.95 | 838.00 | 782.35 | 789.00 | -3.2% | 4,962 |
| Nov 11, 2026 | 806.00 | 818.00 | 806.00 | 814.85 | +1.7% | 1,244 |
| Nov 9, 2026 | 808.90 | 817.35 | 766.05 | 800.90 | +2.9% | 2,350 |
| Nov 6, 2026 | 767.00 | 788.30 | 760.20 | 778.60 | +0.7% | 1,387 |
| Nov 5, 2026 | 768.95 | 777.00 | 761.30 | 773.00 | +0.5% | 1,400 |
| Nov 4, 2026 | 783.65 | 783.90 | 762.20 | 768.95 | -0.0% | 2,187 |
| Nov 3, 2026 | 768.45 | 781.40 | 755.25 | 769.25 | +0.1% | 465 |
| Nov 2, 2026 | 758.80 | 775.00 | 758.80 | 768.45 | +0.7% | 1,045 |
| Oct 30, 2026 | 762.50 | 773.65 | 755.00 | 762.80 | -0.7% | 918 |
| Oct 29, 2026 | 760.00 | 789.40 | 760.00 | 767.95 | -0.5% | 1,589 |
| Oct 28, 2026 | 770.50 | 785.60 | 770.00 | 772.00 | -0.5% | 492 |
| Oct 27, 2026 | 777.10 | 786.70 | 767.55 | 775.70 | -0.2% | 673 |
| Oct 26, 2026 | 763.70 | 785.90 | 756.10 | 777.10 | +1.8% | 3,059 |
| Oct 23, 2026 | 794.75 | 794.90 | 753.35 | 763.70 | -2.6% | 4,202 |
| Oct 22, 2026 | 765.00 | 800.00 | 759.25 | 784.30 | +2.0% | 3,807 |
| Oct 21, 2026 | 797.75 | 799.50 | 765.00 | 768.85 | -3.6% | 1,671 |
| Oct 19, 2026 | 838.95 | 838.95 | 793.00 | 797.75 | -4.0% | 2,510 |
| Oct 16, 2026 | 787.00 | 836.95 | 787.00 | 831.00 | +5.1% | 4,174 |
| Oct 15, 2026 | 809.80 | 810.00 | 781.15 | 790.70 | -1.9% | 2,110 |
| Oct 14, 2026 | 811.25 | 814.95 | 802.05 | 805.80 | -0.7% | 357 |
| Oct 13, 2026 | 794.85 | 826.90 | 784.65 | 811.45 | +3.9% | 3,044 |
| Oct 12, 2026 | 787.65 | 799.90 | 774.70 | 780.85 | -1.4% | 2,793 |
| Oct 9, 2026 | 790.00 | 804.95 | 785.75 | 791.65 | -0.3% | 2,061 |
| Oct 8, 2026 | 810.00 | 817.30 | 781.00 | 793.90 | -2.3% | 6,278 |
| Oct 7, 2026 | 827.30 | 838.55 | 807.20 | 812.75 | — | 4,818 |
Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.
Albert David Limited share price statistics
Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.
Market cap history
World rank over time
Rank in India: #1,013 (Jan 2020) · #1,096 (Jan 2021) · #1,304 (Jan 2022) · #1,412 (Dec 2022) · #1,328 (Jul 2023) · #1,908 (Nov 2026) · #1,910 (Nov 2026) · #1,908 (Nov 2026) · #1,911 (Nov 2026) · #1,911 (Nov 2026) · #1,913 (Nov 2026)
How Albert David Limited compares in Pharmaceutical
- Market cap$46 M · higher than 12% of 393
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Albert David Limited🇮🇳 | $46 M | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Korea United Pharm Inc.$191 M
- Suheung Co., Ltd.$199 M
- JW Holdings Corporation$206 M
- Hester Biosciences Limited$214 M
- Venus Remedies Limited$215 M
- Windlas Biotech Limited$217 M
Sources and freshness
- Market cap:
- Nov 19, 2026
- Profile updated:
- Nov 20, 2026
Figures from Market data, value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Albert David Limited? Verify and update this profile — free
Show Albert David Limited's ranking on your website Get the badge
The badge updates itself as the ranking changes.